Korean scientists have developed a tumor-targeted, bioreducible nanoparticle system that can deliver cytotoxic anticancer drugs to tumor tissues.

Korean scientists have developed a tumor-targeted, bioreducible nanoparticle system that can deliver cytotoxic anticancer drugs to tumor tissues.
New drug delivery method targets cancer cells – not the entire body – and limits chemotherapy side effects.
New core/shell structure nanoparticles have been reported by a team led by Peking University researchers.
Structural transformations of nanoscale boroxines allow the controlled release of guest molecules.
A research team have coated biomaterial surfaces with a naturally expressed molecule that inhibit the inflammatory activation of immune cells.
Nanoparticles can carry two different anti-cancer drugs and deliver them to separate parts of the cancer cell where they will be most effective.
Researchers from Universities in Germany, Brazil, and Israel designed promising multilayer composites applicable as bone fracture fixation devices but also for other orthopedic applications.
A special issue guest-edited by Andreas Lendlein has recently been published in Macromolecular Bioscience. Read selected highlights for free for a limited time!
Researchers develop polymer-based mucus-penetrating particles (MPP) loaded with paclitaxel, a frontline chemo drug.
Progress on the development of polyampholyte polymers for use in biomedical applications is reviewed.